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Summary.-Serial transplantation of an HCG-producing human testicular teratoma
in immune-deprived mice is described. The xenografted tumour was compared to
the tumour of origin in histology, immunohistochemistry (using an immune per-
oxidase technique to localize HCG) autoradiography, marker production and growth
rate. It is concluded that the xenograft retained the characteristics of the original
tumour with the exception of a reduction in HCG-producing elements at transplanta-
tion beyond 5 serial passages.
MALIGNANT testicular teratomas are a
diverse group of rapidly growing human
tumours in which there is a marked
heterogeneity with respect to histopatho-
logy and functional pathology. Many
tumours produce at least 2 marker
substances, human chorionic gonado-
trophin (HCG) and alpha foetoprotein
(AFP). Evidence of differentiation to
mature adult somatic tissues may be pre-
sent in both primary and metastatic
tumour.
As part of an extensive programme in-
vestigating the biology and experimental
therapy of human tumour xenografts, we
have sought to establish malignant tera-
toma tissue as transplantable tumours in
immune-suppressed mice. Precise com-
parison between the tumour of origin and
the xenografted tumour is an essential
initial step, and the present report de-
scribes the growth rate, histology, im-
munohistochemistry, marker production
and 3H-thymidine labelling ofa malignant
trophoblastic teratoma serially trans-
planted in immune-suppressed mice, and
compares the findings to observations
made in tumour material from the donor
patient.
CASE REPORT
The patient, a 21-year-old engineer,
presented in 1975 with multiple pul-
monary metastases discovered on a routine
chest radiograph. On clinical examination
a mass was palpated in the right testis and
several subcutaneous nodules were felt on
the left neck and left shoulder. A right
orchidectomy was performed and histo-
logical examination of the testis showed
the features of a trophoblastic malignant
teratoma according to the criteria of the
British Testicular Tumour Panel (Pugh,
1976). He was referred to the Royal Mars-
den Hospital where a biopsy of a sub-
cutaneous module confirmed metastatic
malignant teratoma. Tissue from the
excised nodule was used to establish the
xenograft.
The patient was treated initially with
2 i.v. injections of cyclophosphamide (5 g)
with forced saline diuresis. The sub-
cutaneous nodules regressed completely
and there was a decrease in the size of the
lung metastases (Fig. 1). This was followed
by 2 courses of a combination of vin-
blastine, actinomycin D and methotrexate
(VAM) and pulmonary irradiation. How-
ever, partial remission was maintained for
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Fia. 1. Growth curves of pulmonary meta-
stases, showing the response to treatment
with cyclophosphamide (CY) and vin-
blastine, actinomycin D and methotrexate
(VAM).
only 3 months, after which relapse
occurred in lung, liver and bone and the
patient died 8 months after presentation.
MATERIALS AND METHODS
Xenografts.-CBA/lac mice were immune-
deprived by thymectomy and whole-body
irradiation (900 rad). In mice used for early
passages, the lethal effects of irradiation were
prevented by reconstitution with syngeneic
marrow. In more recent work it has been
found that marrow reconstitution can be
omitted if whole-body irradiation is preceded
by a single injection of cytosine arabinoside
200 mg/kg (Millar et al., 1978). This latter
method has been found to produce mice more
receptive to xenografted tumours (Steel et al.,
1978) and these mice were used for later pas-
sages. Tumour tissue from the original biopsy
was cut into 2 mm cubes and implanted
s.c. into 5 animals. Tumours were passaged
in a similar manner.
Autoradiography.-With the patient's in-
formed consent, and at the time of surgery,
a subcutaneous metastatic tumour nodule in
the patient was labelled bydirect intranodular
injection of 20 jtCi of [3H]-TdR 20 min before
excision. To label the xenografted tumours,
mice were given an i.p. injection of 50 ,uCi
of [3H]TdR 45 min before excision. Auto-
radiographs were prepared by the dipping
technique using Ilford K5 emulsion. Nuclei
with more than 5 grains were scored as
labelled.
Immanoperoxidase staining. - Human
chorionic gonadotrophin (HCG) was localized
in the cells oftumours by an indirect immuno-
peroxidase technique. The indirect immuno-
peroxidase technique, the method for inhibit-
ing endogenous peroxidase and for preparing
the indirect peroxidase conjugate have been
fully described elsewhere (Nakane & Kawais,
1974; Heyderman, 1979; Heyderman &
Neville, 1976). The first antibody was directed
against the beta subunit of HCG, to avoid
cross-reactivity with the other glycoprotein
hormones (Vaitukaitis et al., 1972). The
second antibody (sheep anti-rabbit) was
raised and purified at this Institute. Each
observation was controlled by ensuring the
extinction of positive staining by incubation
of the antiserum with HCG.
Sections stained by the immunoperoxidase
technique were developed as autoradiographs
without technical modification.
HCG levels-.Blood HCG levels were
measured by radioimmunoassay in the serum
of the patient and the tumour-bearing mice.
Fluid removed from the xenograft tumourMwas
also assayed.
RESULTS
Growth pattern
The growth rate of 2 pulmonary meta-
stases in the patients is shown in Fig. 1.
A volume-doubling time of 11-12 days can
be inferred for the lung deposits at a
volume of 1 cm3, and their regression on
treatment is demonstrated. As a xeno-
graft, the tumour, designated HX36,
grew as a cystic mass containing blood-
stained fluid. Apparent volume-doubling
times for this very cystic tumour were 12
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FIG. 2-5. Indirect immunoperoxidase stain with antiserum to PHCG 1:1000. Counterstain Mayer's
haemalum. Fig. 4 and 5 are also autoradiographs after the immunoperoxidase procedure was
completed. 2. Mouse xenograft. A mixture of mononuclear and multinucleate giant cells show
positive staining. This picture and that in Fig. 3 are indistinguishable from certain areas in the
original primary testicular tumour. x 150. 3. Mouse xenograft. In this area the HCG+ cells are
all mononuclear. x 128. 4. 2° skin nodule in the patient removed 20 min after injection of 20 ,uCi
[3H]TdR. The brown immunoperoxidase reaction product is seen in bizarre multinucleate giant
cells, some including a small blood vessel (left). [3H]TdR labelling is almost entirely confined to
the HCG- cytotrophoblast. x 128. 5. 2° skirn nodule (higher power of Fig. 4). Here the TdR labelling
is seen to be confined to those cells not labelled by the immunoperoxidase stain for HCG. x 320 oil.
days at a volume of 1 cm3 in Passage 1,
and 11 days at the same volume in Passage
6. The latent period before growth was
first detectable was shorter in the later
passage.
Histology and immunohistochemistry
(Fig. 2-5)
Histological examination of the orchid-
ectomy specimen showed a trophoblastic
malignant teratoma which appeared to
consist partly of classical trophoblastic
tumour and partly of undifferentiated
malignant teratoma. There were extensive
areas of haemorrhage and necrosis, with
evidence of vascular and lymphatic per-
meation. The histological appearance of
the secondary skin nodule was essentially
similar. However, staining with the in-
direct immunoperoxidase method for
HCG demonstrated abundant HCG+ cells
in tumour tissue which had appeared to be
undifferentiated malignant teratoma by
conventional histological staining. Most of
the malignant HCG+ syncytiotrophoblast
was multinucleate, but there were large
numbers of HCG+ giant mononuclear cells
scattered amongst the malignant cyto-
trophoblast.
The first 5 xenograft passages showed
remarkably similar histological and stain-
ing properties, and the content of differ-
entiated HCG+ cells was similar. However,
whereas in the early passages the HCG+
cells were mainly mononuclear, by the
5th passage a much larger number were
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multinucleate. In contrast, in the 6th and
most recent passage the tumour was
less differentiated and consisted of large
anaplastic tumour cells tending to be
arranged in acini about an area of
central necrosis. Only one multinucleate
HCG+ cell was identified.
Tumour staining by the immunoperoxi-
dase technique was completely abolished
by incubation of the antiserum with
3HCG and the result was a satisfactory
negative control. However, there remained
2unresolvedproblems. Somecollagenstain-
ing persisted, probably due to an as yet
undefined minor contaminating antibody.
Inthenegative control, macrophageswhich
were not stained in the test slides, were
stained. This is possibly due to the per-
sistence of Fe receptors on these cells,
causing the attachment of immune com-
plexes of HCG and antibody, and is the
subject of a separate study now in pro-
gress.
Autoradiography (Fig. 4 and 5)
Autoradiographs of the metastatic
tumour from the patient showed an overall
labelling index (LI) of39%, but there was
wide variation between different high-
power microscopic fields (range 0-70%).
In an autoradiograph ofthe xenograft the
overall LI was 28% and labelled cells were
more evenly distributed (range 18-42%).
However there was a gradient of LI from
the outer edges ofthe cystic mass where it
was maximal at 350o (24-42%) towards
the inner edges of the cyst wall where it
had fallen to 21% (18-23%). In the pre-
parations where both autoradiography
and immunoperoxidase staining were car-
ried out, very little uptake of [3H]TdR
was seen in the cells staining for HCG.
This was the case for both the xenograft
and the original tumour.
Serum and tumour 3HCG
3HCG was measured in the serum of
xenograft-bearing mice on 3 occasions in
different passages. On each occasion the
tumours were of maximum tolerated size
(, 2 cm3). The levels were 500, 180 and
39
2-6 ,tg/lin Passages 3, 4 and 6 respectively.
The HCG levels in fluid removed from
the centre ofthe xenografted tumour were
extremely high, being 36,000, 22,500 and
19,000 jug/l in Passages 2, 3 and 4 respec-
tively.
Only a single measurement of 3HCG
was made in the patient's serum, and this
was found to be 7-5 ,tg/l after his therapy
with cyclophosphamide.
DISCUSSION
Several authors have reported growth
ofhuman testicular teratomas in immune-
deficient mice (Berenbaum et al., 1974;
Giovanella et al., 1974) and have observed
maintenance of the histological structure
of the tumour in the first implantation.
Serial transplantation of these tumours in
immune-deficient mice was not examined.
However, Pierce was able to maintain
several human testicular tumours in the
cheekpouch ofcortisone-treated hamsters,
and found that their histological structure
was retained and HCG production was
demonstrated by bio-assay (see Verney
et al., 1959).
The xenografted tumour in the present
report retained several important charac-
teristics of the parent human tumour,
namely histology and histochemistry, de-
gree of differentiation and production of a
marker hormone. However, the decrease
in the content of HCG-producing cells and
the concomitant fall in serum marker
levels found with repeated passage, sug-
gest that sequential transplantation
caused a loss of the HCG-producing
elements. The results of simultaneous
autoradiography and immunoperoxidase
histochemistry indicate that the HCG+
cells predominantly constitute a non-
dividing population. One interpretation of
these observations would be that the
HCG-producing cells represent a differ-
entiated population of non-proliferating
cells, and that in this tumour serial trans-
plantation has selected the undiffer-
entiated proliferating cells, although we
have not investigated cell proliferation
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kinetics in these late tumours. Studies in
xenografted tumours such as colorectal
adenocarcinoma, where changes in differ-
entiation may be assessed histologically,
have not demonstrated loss of differenti-
ation with serial transplantation (Hough-
ton & Taylor, 1978). The converse, that is,
a change towards a more differentiated
pattern, has recently been described by
Sharkey et al. (1977).
The volume-doubling time of the
patient's lung metastases in this tumour
is within the range generally reported for
this group of tumours (Garretta et al.,
1970). It is of interest, and perhaps co-
incidental, that the xenografted tumour
grew at about the same rate. The cystic
nature of the tumour prevents accurate
estimation ofthe doubling time oftumour
tissue. There are few data comparing in
detail the growth rate of different histo-
logical groups of tumours as xenografts
and in patients, but the general conclusion
has been that xenografted tumours tend
to grow more rapidly than human tumours
in situ (Lamerton & Steel, 1975).
We are unaware ofany previous reports
of the labelling index of human germ-cell
tumours of the testis. The high labelling
index of the patient's nodule, in this case,
is comparable to other rapidly growing
human tumours such as the diffuse
lymphomas (Steel, 1977). However, the
non-homogeneous pattern of labelling
makes the interpretation of the data
somewhat unreliable, and may indicate a
non-uniform distribution ofthe label after
injection into the nodule. Despite the
limitations, it can be seenthat the labelling
index of the original tumour lies in the
same range as the better perfused outer
parts of the xenografted tumour.
These studies suggest an encouragingly
close relationship between this xenograft
and its parent tumour, with the exception
of the loss of HCG-producing cells with
serial passage. In more recent work, we
have succeeded in initiating growth in a
further 6 testicular tumour xenografts,
and these are presently in early passage
undergoing further investigation. Such
tumours would seem to have potential as
models for studying the differentiation of
human tumours and their experimental
therapy.
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